PDF factsheet
      Z

ticagrelor for cardiovascular prevention clinical trials results

ticagrelor versus clopidogrel
EUCLID, 2016
NCT01732822
ticagrelor (90 mg twice daily)
versus
clopidogrel (75 mg once daily)
patients with symptomatic peripheral artery disease
Follow-up duration: 30 months (median)

  Options


in first

in second

  Filter